Insulet Balance Sheet Health
Financial Health criteria checks 4/6
Insulet has a total shareholder equity of $790.7M and total debt of $1.4B, which brings its debt-to-equity ratio to 177.2%. Its total assets and total liabilities are $2.6B and $1.8B respectively. Insulet's EBIT is $265.0M making its interest coverage ratio 44.2. It has cash and short-term investments of $751.2M.
Key information
177.2%
Debt to equity ratio
US$1.40b
Debt
| Interest coverage ratio | 44.2x |
| Cash | US$751.20m |
| Equity | US$790.70m |
| Total liabilities | US$1.83b |
| Total assets | US$2.62b |
Recent financial health updates
Is Insulet (NASDAQ:PODD) A Risky Investment?
Apr 29
Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jan 09We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt
Oct 01Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jun 18Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden
Jan 24Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet
Oct 02Recent updates
Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023
Jun 11We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
May 26At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?
May 12Is Insulet (NASDAQ:PODD) A Risky Investment?
Apr 29Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Apr 14Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)
Mar 31Insulet: Insulating Patients, Investors Still Have To Wait
Mar 28Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price
Feb 19Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?
Jan 22Insulet: An Interesting, Yet Expensive, Story
Jan 10Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jan 09Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Dec 27Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Nov 14Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Oct 31We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt
Oct 01Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Sep 16Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Aug 14Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Jul 31Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jun 18Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult
May 22Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Apr 30Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden
Jan 24Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Dec 28Insulet: An Overpriced Play In The Medical Space
Oct 18Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet
Oct 02Insulet automated insulin delivery system Omnipod 5 gets CE mark
Sep 20The Return Trends At Insulet (NASDAQ:PODD) Look Promising
Sep 05Financial Position Analysis
Short Term Liabilities: PODD's short term assets ($1.6B) exceed its short term liabilities ($432.4M).
Long Term Liabilities: PODD's short term assets ($1.6B) exceed its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: PODD's net debt to equity ratio (82.2%) is considered high.
Reducing Debt: PODD's debt to equity ratio has reduced from 268.1% to 177.2% over the past 5 years.
Debt Coverage: PODD's debt is not well covered by operating cash flow (16.6%).
Interest Coverage: PODD's interest payments on its debt are well covered by EBIT (44.2x coverage).